Home › Funds › Citadel Advisors › DCPH
Citadel Advisors position in DCPH
DECIPHERA PHARMACEUTICALS IN
Latest position (Q1 2024)115.95K sh
Reported value held$1.82M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 111.23K | $3.78M | New |
| Q4 2021 | 381.91K | $3.73M | Add |
| Q1 2022 | 333.44K | $3.09M | Reduce |
| Q2 2022 | 315.21K | $4.14M | Reduce |
| Q3 2022 | 295.24K | $5.46M | Reduce |
| Q4 2022 | 188.45K | $3.09M | Reduce |
| Q1 2023 | 172.91K | $2.67M | Reduce |
| Q3 2023 | 239.62K | $3.05M | New |
| Q4 2023 | 266.99K | $4.31M | Add |
| Q1 2024 | 115.95K | $1.82M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.